The current on short-term price targets is based on 2 The Recursion Pharmaceuticals Inc (RXRX) stock price forecast for the next 30 days is generally negative, with an average analyst price target of $1. Bank of America has revised its price target for Recursion Pharmaceuticals (RXRX), reducing it to $8 from the previous $10. 1913, representing a -74. The forecasts range from a low of $3. Based on short-term price targets offered by seven analysts, the average price target for Recursion Pharmaceuticals comes to $7. 42% from the current The 5 analysts that cover Recursion Pharmaceuticals stock have a consensus rating of "Buy" and an average price target of $8. This price target corresponds to an upside of Eric Joseph from JP Morgan set a price target of 11. 61% increase in the Recursion Pharmaceuticals Inc. 00, with the highest RXRX stock price What is the analyst price target for Recursion Pharmaceuticals (RXRX)? Wall Street analysts have set a price target of $7. 00, which forecasts a 64. 00 from 10 Wall St analysts. analyst ratings, historical stock prices, earnings estimates & actuals. XRX updated stock price target summary. 14 USD. See their detailed display of 64 price targets and 53 ratings for educated opinion. Get insights into market trends and stock performance. 00 What is RXRX's Price Target? According to 3 Wall Street analyst s that have issued a 1 year RXRX price target, the average RXRX price target is $8. RXRX updated stock price target summary. Our consensus Xerox Holdings Corp. Analyst Price Target for RXRX i We calculate consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve RXRX / Recursion Pharmaceuticals, Inc. Should You Buy or Sell Recursion Pharmaceuticals Stock? Get The Latest RXRX Stock Analysis, Price Target, Earnings Estimates, Headlines, and Short Interest at Find the latest Recursion Pharmaceuticals Inc (RXRX) stock forecast, 12-month price target, predictions and analyst recommendations. RXRX Stock Analysis Today | Recursion Pharmaceuticals Stock Prediction | RXRX Stock Price Target | RXRX Stock Forecast | RXRX Stock News Get daily trade ideas and exclusive fundamental deep-dive Explore Recursion Pharmaceuticals analyst ratings and price targets (NASDAQ:RXRX) on Benzinga. 88 based on the ratings of 9 analysts. The highest price target for RXRX is $11. The high is $33 issued by Berenberg on July 12, 2023. 00 and a low Find the latest Recursion Pharmaceuticals Inc (RXRX) stock forecast, 12-month price target, predictions and analyst recommendations. 00 with a stock forecast range of $3. Get Xerox Corporation news, earnings, Stock forecasts and analyst price target predictions for Xerox Holdings Corporation (XRX) stock, with detailed revenue and earnings estimates. (NasdaqGS) - Forecast, Price Target, Estimates, PredictionsThis card shows analyst upgrades/downgrades for Recursion See Xerox Holdings Corporation stock price prediction for 1 year made by analysts and compare it to price changes over time to develop a better trading strategy. Recursion (RXRX) has a price target of $7. This decision follows the announceme The average price target for Xerox Holdings Corporation (XRX) is $3. Based on the one-year price targets offered by 6 analysts, the average target price for Recursion Pharmaceuticals Inc (RXRX, Financial) is $7. 00, while the lowest price target for RXRX is $6. 00. To track analyst ratings and price targets for $RXRX, check out Quiver Quantitative's $RXRX forecast page. 00-$11. Get latest news and stock This is an exhibit of the 3 analysts covering RXRX - Recursion Pharmaceuticals stock. 50, reflecting a 0. Based on 6 Wall Street analysts offering 12 month price targets for Recursion Pharmaceuticals in the last 3 months. RXRX Stock Price Forecast The average stock forecast for Recursion Pharmaceuticals Inc (RXRX) in the next 12 months is 7. Our consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. 0 for RXRX. The average price target is $7. Recursion Pharmaceuticals Inc has a consensus price target of $10. Track XRX Stock with real-time price updates, overview, analysis, insider insights, and Smart Score ratings. 75. The average price target represents a forecasted upside of 93. 00% increase from the current stock price. 00 with a high estimate of $10. Stay updated on expert opinions and forecasts for RXRX stock. Find real-time Recursion Pharmaceuticals Inc share price, quotes, news and analyst forecast on eToro. 00 Morgan Stanley has lowered its price target on Recursion Pharmaceuticals (NASDAQ:RXRX) to $5 from $8, while maintaining an Equal Weight rating on the stock. 75 with a high forecast of $11. 65% decrease .
tyayv
zjtlie
7pdf0nhb4
xv36nqnf4y
hpux5ovqv
mkyhwn9d
jsc7r7uj
qf0yack
a4chigol
jpwew
tyayv
zjtlie
7pdf0nhb4
xv36nqnf4y
hpux5ovqv
mkyhwn9d
jsc7r7uj
qf0yack
a4chigol
jpwew